Bsenexus Terminal Open Filings terminal →
Conference call BSE: 532296

Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Initmation of Schedule of Analyst/ Institutional Investor Meetings